Eisai shutters oncology unit, cuts around 80 jobs

Nicole DeFeudis

Editor

Days after announcing a reorganization plan to focus on deep learning and its “most important project,” the Biogen-partnered Alzheimer’s drug lecanemab, Eisai is shuttering its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Eisai shutters oncology unit, cuts around 80 jobs

Nicole DeFeudis

Editor

Sign up to read this article for free.

Pfizer hires ex-FDA deputy Patrizia Cavazzoni as chief medical officer

Post-Hoc: Pharma CEOs' alternative reality with Trump

Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos

FDA lifts hold on Entrada's Duchenne drug after two years

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

How AI can address ongoing challenges in the life sciences industry

Ei­sai shut­ters on­col­o­gy unit, cuts around 80 jobs

Nicole DeFeudis

Editor

Sign up to read this article for free.

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

FDA lifts hold on En­trada's Duchenne drug af­ter two years

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

Eisai shutters oncology unit, cuts around 80 jobs

Pfizer hires ex-FDA deputy Patrizia Cavazzoni as chief medical officer

Post-Hoc: Pharma CEOs' alternative reality with Trump

Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos

FDA lifts hold on Entrada's Duchenne drug after two years

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

How AI can address ongoing challenges in the life sciences industry